全文获取类型
收费全文 | 177451篇 |
免费 | 50423篇 |
国内免费 | 3127篇 |
专业分类
耳鼻咽喉 | 3042篇 |
儿科学 | 5458篇 |
妇产科学 | 2158篇 |
基础医学 | 31087篇 |
口腔科学 | 6887篇 |
临床医学 | 22218篇 |
内科学 | 41146篇 |
皮肤病学 | 10143篇 |
神经病学 | 19954篇 |
特种医学 | 7550篇 |
外国民族医学 | 7篇 |
外科学 | 26564篇 |
综合类 | 5834篇 |
现状与发展 | 5篇 |
一般理论 | 55篇 |
预防医学 | 9694篇 |
眼科学 | 3906篇 |
药学 | 15777篇 |
18篇 | |
中国医学 | 4043篇 |
肿瘤学 | 15455篇 |
出版年
2024年 | 178篇 |
2023年 | 1000篇 |
2022年 | 2028篇 |
2021年 | 5535篇 |
2020年 | 7189篇 |
2019年 | 13137篇 |
2018年 | 13006篇 |
2017年 | 13600篇 |
2016年 | 14878篇 |
2015年 | 16147篇 |
2014年 | 16880篇 |
2013年 | 17922篇 |
2012年 | 13199篇 |
2011年 | 12837篇 |
2010年 | 13830篇 |
2009年 | 9530篇 |
2008年 | 8212篇 |
2007年 | 6689篇 |
2006年 | 6148篇 |
2005年 | 5580篇 |
2004年 | 4694篇 |
2003年 | 4513篇 |
2002年 | 4097篇 |
2001年 | 3671篇 |
2000年 | 3237篇 |
1999年 | 2300篇 |
1998年 | 954篇 |
1997年 | 807篇 |
1996年 | 656篇 |
1995年 | 552篇 |
1994年 | 492篇 |
1993年 | 363篇 |
1992年 | 772篇 |
1991年 | 680篇 |
1990年 | 670篇 |
1989年 | 614篇 |
1988年 | 568篇 |
1987年 | 509篇 |
1986年 | 416篇 |
1985年 | 365篇 |
1984年 | 281篇 |
1983年 | 229篇 |
1982年 | 145篇 |
1981年 | 150篇 |
1980年 | 123篇 |
1979年 | 221篇 |
1978年 | 156篇 |
1977年 | 108篇 |
1975年 | 112篇 |
1974年 | 118篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
105.
106.
107.
108.
Comparative outcomes of vascular access in patients older than 70 years with end-stage renal disease
Deokbi Hwang Sujin Park Hyung-Kee Kim Seung Huh 《Journal of vascular surgery》2019,69(4):1196-1206.e5
Objective
The advantage of arteriovenous fistulas (AVFs) in older patients requiring dialysis is controversial. We reviewed our vascular access experience in patients ≥70 years of age (older group) compared with younger patients.Methods
We analyzed consecutive patients who underwent access surgery between 2013 and 2016. Primary success (PS) and primary patency (PP) data were analyzed between the older and younger groups before and after propensity score matching of the patients' characteristics and access composition. PS was defined as the achievement of access function that was amenable to two sessions of successful cannulation without early occlusion or maturation failure requiring revision. PP was defined as the time with uninterrupted patency without intervention.Results
A total of 594 consecutive accesses were created among 563 patients, of whom 119 were allocated into each group after propensity score matching. In the whole cohort, 193 accesses (32.5%) were performed in older patients. AVFs were performed in 130 (67.4%) older patients and 293 (73.1%) younger patients. Regarding AVFs, the PS rate (83.6% in the older group vs 94.3% in the younger group; P = .001) and the overall PP at 6 and 12 months (73.1% and 57.1%, respectively, in the older group vs 86.7% and 77.7%, respectively, in the younger group; P = .009) were lower in the older group than in the younger group. However, no differences were found in the PS and PP rates for arteriovenous grafts between groups. Regarding the AVF location, the PS rate for forearm AVFs was significantly lower in the older group than in the younger group (76% vs 93%; P < .001); however, the PS rate of the upper arm was not different between the groups (94% vs 97%; P = .425). In the patients with PS, the PP rate of AVFs was similar between the two groups. In the older group with forearm AVFs, the median diameter of the radial artery was larger in the patients with PS than in the patients without PS (2.20 mm with PS vs 2.00 mm without PS; P = .008). The propensity score matching results demonstrated similar trends for the whole cohort, with lower PS (P = .042) and PP rates (P = .023) for AVF in the older group.Conclusions
The outcomes after AVF were poorer in the older group than in the younger group, which was primarily due to unsatisfactory outcomes in patients with forearm AVFs. Thus, stricter criteria, especially regarding the radial artery diameter, should be applied for forearm AVFs in older patients, and additional research is necessary to delineate the risk factors for primary failure. 相似文献109.
Tuberculosis (TB) remains one of a major health problem worldwide. Tuberculosis vaccine research has made an extraordinary progress over the past few years. However, there is still no replacement for the Bacillus Calmette‐Guérin vaccine, the only TB vaccine licensed for human use. Therefore, the discovery and development of new TB vaccines remains a priority. This article discusses current strategies used to diversify TB vaccines and includes discussion of the status of efforts to improve protection against Mycobacterium tuberculosis (M tb) infection or TB disease by developing new and safe TB vaccines. This article also highlights the current research efforts in immune‐enhancing approaches to improve vaccination efficacy. The development of more effective TB vaccines might have significant impact on global TB control. 相似文献
110.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献